HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Darryl C Zeldin Selected Research

Neoplasms (Cancer)

1/2023CYP eicosanoid pathway mediates colon cancer-promoting effects of dietary linoleic acid.
10/2020Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis.
1/2020Role of linoleic acid-derived oxylipins in cancer.
1/2019Introduction.
1/2019Prediagnostic Serum Levels of Fatty Acid Metabolites and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
1/2019Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon Tumorigenesis.
11/2014Reproductive and hormonal risk factors for antinuclear antibodies (ANA) in a representative sample of U.S. women.
7/2013Regulation of T helper cell subsets by cyclooxygenases and their metabolites.
1/2012Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice.
12/2011EET signaling in cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Darryl C Zeldin Research Topics

Disease

57Inflammation (Inflammations)
04/2024 - 06/2002
45Asthma (Bronchial Asthma)
03/2024 - 02/2003
18Neoplasms (Cancer)
01/2023 - 06/2005
16Hypertension (High Blood Pressure)
05/2017 - 03/2003
12Ischemia
01/2023 - 09/2004
10Fibrosis (Cirrhosis)
04/2024 - 09/2007
10Hypersensitivity (Allergy)
05/2019 - 12/2005
9Insulin Resistance
11/2017 - 11/2003
8Obesity
04/2024 - 05/2009
8Hyperemia
09/2023 - 05/2009
7Cardiovascular Diseases (Cardiovascular Disease)
09/2023 - 06/2012
7Pneumonia (Pneumonitis)
06/2022 - 11/2003
7Reperfusion Injury
05/2020 - 01/2007
7Respiratory Hypersensitivity
04/2017 - 07/2006
6Infections
01/2023 - 06/2004
6Seasonal Allergic Rhinitis (Hay Fever)
01/2020 - 11/2006
6Pulmonary Fibrosis (Fibrosing Alveolitis)
11/2011 - 01/2002
4Hypertrophy
04/2024 - 01/2013
4Human Influenza (Influenza)
06/2022 - 11/2005
4Choroidal Neovascularization
01/2022 - 01/2016
4Lung Diseases (Lung Disease)
01/2018 - 06/2006
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2016 - 10/2004
4Dyslipidemias (Dyslipidemia)
07/2015 - 12/2010
4Cardiomegaly (Heart Hypertrophy)
03/2015 - 01/2013
4Carcinoma (Carcinomatosis)
11/2011 - 06/2005
3Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2024 - 12/2010
3Heart Failure
04/2024 - 03/2012
3Carcinogenesis
01/2023 - 01/2012
3Vascular Diseases (Vascular Disease)
01/2020 - 05/2002
3Pathologic Neovascularization
01/2016 - 03/2014
3Body Weight (Weight, Body)
07/2015 - 07/2009
3Ischemic Stroke
01/2013 - 10/2005
3Diabetic Nephropathies (Diabetic Nephropathy)
09/2012 - 05/2007
3Neoplasm Metastasis (Metastasis)
01/2012 - 07/2007
2Fatty Liver
04/2024 - 01/2014
2Cardiomyopathies (Cardiomyopathy)
02/2024 - 01/2021
2Hypoxia (Hypoxemia)
12/2023 - 01/2018
2Pulmonary Hypertension
12/2023 - 12/2010
2Colonic Neoplasms (Colon Cancer)
01/2023 - 01/2019
2COVID-19
01/2023 - 11/2020

Drug/Important Bio-Agent (IBA)

43Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
04/2024 - 03/2003
35AllergensIBA
03/2024 - 02/2003
31Cytochrome P-450 CYP2J2 (CYP2J2)IBA
05/2020 - 09/2004
28Epoxide HydrolasesIBA
04/2024 - 10/2005
28AcidsIBA
01/2024 - 11/2003
22EicosanoidsIBA
01/2023 - 05/2002
18Arachidonic Acid (Vitamin F)IBA
01/2024 - 11/2003
14LipidsIBA
04/2024 - 12/2011
13EnzymesIBA
01/2023 - 08/2002
13Proteins (Proteins, Gene)FDA Link
09/2020 - 11/2003
12OxylipinsIBA
04/2024 - 01/2016
12Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2020 - 08/2002
10Fatty Acids (Saturated Fatty Acids)IBA
04/2024 - 01/2007
9CytokinesIBA
11/2021 - 11/2005
9EndotoxinsIBA
01/2020 - 12/2005
8Immunoglobulin E (IgE)IBA
01/2018 - 05/2009
8Cytochrome P-450 CYP2C8IBA
11/2016 - 01/2005
7Glucose (Dextrose)FDA LinkGeneric
09/2020 - 04/2010
6Oxygen (Dioxygen)IBA
12/2023 - 06/2006
6Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2016 - 09/2007
6CytochromesIBA
01/2016 - 06/2002
6C-Reactive ProteinIBA
02/2013 - 02/2009
5CollagenIBA
04/2024 - 09/2007
5Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
04/2024 - 03/2014
5Linoleic Acid (Linoleate)IBA
01/2023 - 10/2012
5Mixed Function Oxygenases (Monooxygenases)IBA
01/2023 - 04/2013
5ProstaglandinsIBA
10/2020 - 11/2005
5Insulin (Novolin)FDA Link
09/2020 - 05/2007
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020 - 12/2016
5cytochrome P-450 CYP2C subfamilyIBA
12/2019 - 10/2003
5Protein Isoforms (Isoforms)IBA
12/2019 - 10/2011
5LipopolysaccharidesIBA
01/2018 - 07/2006
5Streptozocin (Streptozotocin)FDA Link
11/2017 - 05/2007
520-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
05/2017 - 11/2003
5Bleomycin (Blenoxane)FDA LinkGeneric
01/2016 - 09/2007
5Gonadal Steroid Hormones (Sex Hormones)IBA
12/2009 - 01/2007
4Angiotensin IIIBA
09/2023 - 10/2003
4Dust (House Dust)FDA Link
01/2020 - 12/2005
4Retinaldehyde (Retinal)IBA
11/2016 - 08/2013
4OvalbuminIBA
10/2013 - 06/2010
4FructoseIBA
04/2010 - 11/2003
3AntioxidantsIBA
06/2022 - 11/2011
3Cyclooxygenase 1IBA
01/2021 - 11/2005
3Dinoprostone (PGE2)FDA Link
01/2020 - 11/2005
3ORALIT (ORS)IBA
01/2020 - 11/2006
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2016 - 12/2014
314,15-epoxy-5,8,11-eicosatrienoic acidIBA
01/2015 - 02/2010
3Antihypertensive Agents (Antihypertensives)IBA
09/2012 - 04/2010
3Prostaglandins EIBA
11/2011 - 08/2002
3AngiotensinsIBA
10/2010 - 03/2003
3SaltsIBA
10/2010 - 03/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2009 - 06/2004
3Tissue Kallikreins (Tissue Kallikrein)IBA
04/2008 - 11/2003
2Epoxy Compounds (Epoxides)IBA
04/2024 - 03/2014
2ThromboxanesIBA
03/2024 - 01/2020
2Indicators and Reagents (Reagents)IBA
01/2024 - 01/2020
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
12/2023 - 05/2017
2LigandsIBA
12/2023 - 11/2012
2MucinsIBA
01/2023 - 02/2009

Therapy/Procedure

10Therapeutics
03/2024 - 05/2006